A team of scientists in Massachusetts has noted that the antimullerian hormone (AMH) could prevent chemotherapy-induced ovarian damage.
Pre-clinical trials in mice have highlighted that this hormone stops the egg maturation process in the ovarian follicles. This property is not a discovery per se but the use of anti-mullerian hormone to preserve the follicles during chemotherapy is a hitherto unexplored option. Chemotherapy depletes ovarian reserves by stimulating these main follicles. Anti-mullerian hormone injections could “cause follicles to hibernate” during treatment. As the process is reversible, these follicles resume their natural development following chemotherapy. An alternative to egg freezing that warrants closer study.
In Texas, Brian Hermann’s team has shown that injections of granulocyte colony-stimulating factors (G-CSF) could prevent the loss of masculine fertility following chemotherapy or radiotherapy. This molecule has been used to date to prevent infections in these patients because it stimulates the immune system. Scientists have shown that it also stimulates the production of new sperm stem cells. “This suggests that G-CSF could be used as a retrospective treatment in restoring fertility”, they concluded. Brian Hermann who is following the research, believes that this could be a “creative solution”.